CAVU Biotherapies
PrivateLast Round
Debt
Mar 4, 2019
Total Funding Raised
$50,000
Company Overview
CAVU Biotherapies operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Debt round in March 2019.
CAVU Biotherapies is a biotechnology company that develops personalized immune-based therapies for the treatment of cancer and autoimmune diseases in pets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CAVU Biotherapies Comparables
Compare CAVU Biotherapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ELIAS Animal Health | 93% | |
| Torigen Pharmaceuticals, Inc. | 85% | |
| FidoCure | 79% |
For institutional investors. Book with your work email.
CAVU Biotherapies Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
CAVU Biotherapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital Factory | Accelerator |
| Houston Angel Network | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2019
$50K debt round closed.
For institutional investors. Book with your work email.
CAVU Biotherapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CAVU Biotherapies's valuation, stock price, and market status.
Is CAVU Biotherapies a public or private company?
CAVU Biotherapies is a private company.
What is the current stock price of CAVU Biotherapies?
CAVU Biotherapies is a private company, so its shares have no public market price. Caplight tracks CAVU Biotherapies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CAVU Biotherapies worth (valuation)?
Valuation information for CAVU Biotherapies is not publicly available.
Can I buy CAVU Biotherapies stock?
CAVU Biotherapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CAVU Biotherapies's last funding round?
CAVU Biotherapies's most recent funding round was Debt on March 4, 2019.
Who are the main investors in CAVU Biotherapies?
Key investors in CAVU Biotherapies include Capital Factory, Houston Angel Network.
Will CAVU Biotherapies IPO soon?
No public IPO plans have been announced for CAVU Biotherapies.
How can I track CAVU Biotherapies secondary market activity?
Caplight tracks bids, offers, and trades in CAVU Biotherapies's shares on secondary markets.